(IRM) Iron Mountain - Ratings and Ratios
Records, Data, Centers, Destruction, Cloud
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.49% |
| Yield on Cost 5y | 13.31% |
| Yield CAGR 5y | 6.78% |
| Payout Consistency | 90.5% |
| Payout Ratio | 1.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 31.0% |
| Value at Risk 5%th | 50.5% |
| Relative Tail Risk | -1.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.36 |
| Alpha | -29.22 |
| CAGR/Max DD | 0.67 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.645 |
| Beta | 1.011 |
| Beta Downside | 1.270 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.03% |
| Mean DD | 10.75% |
| Median DD | 5.74% |
Description: IRM Iron Mountain December 17, 2025
Iron Mountain Inc. (NYSE: IRM) provides information-management services to over 240,000 customers across 61 countries, covering roughly 95 % of the Fortune 1000. Its portfolio spans physical and digital records storage, data-center colocation, secure shredding, and asset-lifecycle solutions, all built on a foundation of safety, security, sustainability, and ongoing innovation.
Key metrics that shape IRM’s outlook include a ~ 10 % year-over-year growth in digital-storage revenue (driven by enterprise cloud-migration and regulatory data-retention mandates) and a ~ 7 % operating margin expansion from 2022-2024 as the company leverages higher-value digital services. The REIT’s performance is also sensitive to macro-factors such as corporate capital-expenditure cycles, data-privacy legislation (e.g., GDPR, CCPA), and the broader demand for secure, off-site data-center capacity amid rising cyber-risk concerns.
For a deeper, data-driven assessment of IRM’s valuation and risk profile, you might explore the analytics platform ValueRay, which aggregates real-time financial and sector data to help pinpoint high-expected-value opportunities.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (159.3m TTM) > 0 and > 6% of Revenue (6% = 398.4m TTM) |
| FCFTA -0.06 (>2.0%) and ΔFCFTA -3.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -14.68% (prev -9.81%; Δ -4.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 1.27b > Net Income 159.3m (YES >=105%, WARN >=100%) |
| Net Debt (18.28b) to EBITDA (2.08b) ratio: 8.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (298.0m) change vs 12m ago 1.49% (target <= -2.0% for YES) |
| Gross Margin 55.63% (prev 56.43%; Δ -0.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 33.96% (prev 32.42%; Δ 1.54pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.28 (EBITDA TTM 2.08b / Interest Expense TTM 822.2m) >= 6 (WARN >= 3) |
Altman Z'' -1.05
| (A) -0.05 = (Total Current Assets 1.88b - Total Current Liabilities 2.86b) / Total Assets 20.63b |
| (B) -0.25 = Retained Earnings (Balance) -5.24b / Total Assets 20.63b |
| (C) 0.05 = EBIT TTM 1.05b / Avg Total Assets 19.55b |
| (D) -0.26 = Book Value of Equity -5.61b / Total Liabilities 21.24b |
| Total Rating: -1.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 37.79
| 1. Piotroski 2.0pt |
| 2. FCF Yield -2.48% |
| 3. FCF Margin -17.44% |
| 4. Debt/Equity -20.95 |
| 5. Debt/Ebitda 8.81 |
| 6. ROIC - WACC (= -0.08)% |
| 7. RoE -22.34% |
| 8. Rev. Trend 98.67% |
| 9. EPS Trend -24.78% |
What is the price of IRM shares?
Over the past week, the price has changed by +0.24%, over one month by +13.98%, over three months by -11.82% and over the past year by -13.73%.
Is IRM a buy, sell or hold?
- Strong Buy: 4
- Buy: 5
- Hold: 0
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the IRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 116 | 25.6% |
| Analysts Target Price | 116 | 25.6% |
| ValueRay Target Price | 107.2 | 16.1% |
IRM Fundamental Data Overview January 18, 2026
P/E Forward = 49.2611
P/S = 4.2706
P/B = 1516.5122
P/EG = 1.08
Revenue TTM = 6.64b USD
EBIT TTM = 1.05b USD
EBITDA TTM = 2.08b USD
Long Term Debt = 15.49b USD (from longTermDebt, last quarter)
Short Term Debt = 699.3m USD (from shortTermDebt, last quarter)
Debt = 18.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.28b USD (from netDebt column, last quarter)
Enterprise Value = 46.64b USD (28.36b + Debt 18.48b - CCE 195.2m)
Interest Coverage Ratio = 1.28 (Ebit TTM 1.05b / Interest Expense TTM 822.2m)
EV/FCF = -40.28x (Enterprise Value 46.64b / FCF TTM -1.16b)
FCF Yield = -2.48% (FCF TTM -1.16b / Enterprise Value 46.64b)
FCF Margin = -17.44% (FCF TTM -1.16b / Revenue TTM 6.64b)
Net Margin = 2.40% (Net Income TTM 159.3m / Revenue TTM 6.64b)
Gross Margin = 55.63% ((Revenue TTM 6.64b - Cost of Revenue TTM 2.95b) / Revenue TTM)
Gross Margin QoQ = 54.85% (prev 55.91%)
Tobins Q-Ratio = 2.26 (Enterprise Value 46.64b / Total Assets 20.63b)
Interest Expense / Debt = 1.14% (Interest Expense 209.7m / Debt 18.48b)
Taxrate = 16.14% (16.6m / 102.8m)
NOPAT = 883.3m (EBIT 1.05b * (1 - 16.14%))
Current Ratio = 0.66 (Total Current Assets 1.88b / Total Current Liabilities 2.86b)
Debt / Equity = -20.95 (negative equity) (Debt 18.48b / totalStockholderEquity, last quarter -882.0m)
Debt / EBITDA = 8.81 (Net Debt 18.28b / EBITDA 2.08b)
Debt / FCF = -15.79 (negative FCF - burning cash) (Net Debt 18.28b / FCF TTM -1.16b)
Total Stockholder Equity = -712.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.81% (Net Income 159.3m / Total Assets 20.63b)
RoE = -22.34% (negative equity) (Net Income TTM 159.3m / Total Stockholder Equity -712.8m)
RoCE = 7.13% (EBIT 1.05b / Capital Employed (Equity -712.8m + L.T.Debt 15.49b))
RoIC = 6.14% (NOPAT 883.3m / Invested Capital 14.39b)
WACC = 6.21% (E(28.36b)/V(46.83b) * Re(9.64%) + D(18.48b)/V(46.83b) * Rd(1.14%) * (1-Tc(0.16)))
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.50%
Fair Price DCF = unknown (Cash Flow -1.16b)
EPS Correlation: -24.78 | EPS CAGR: -45.50% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.67 | Revenue CAGR: 11.67% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.48 | Chg30d=-0.007 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=2.27 | Chg30d=+0.003 | Revisions Net=+2 | Growth EPS=+11.0% | Growth Revenue=+10.6%
Additional Sources for IRM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle